-+ 0.00%
-+ 0.00%
-+ 0.00%

Rhythm Pharmaceuticals rises; CHMP recommends expanding IMCIVREE EU authorization for acquired hypothalamic obesity, EC decision due Q2 2026

Reuters·03/26/2026 13:04:23

Please log in to view news